HSP27 regulates viability and migration of cancer cell lines following irradiation

Benjamin Philipp Ernst1, Nadine Wiesmann1, Rita Gieringer1

  • 1Department of Otorhinolaryngology, University Medical Center Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany.

Insights

Combining radiotherapy with targeted therapies, specifically inhibiting heat shock protein 27 (HSP27) phosphorylation, shows promise in overcoming cancer treatment resistance and reducing cell viability and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Cancer treatment resistance limits radiotherapy efficacy.
  • Targeted therapies combined with irradiation present a promising strategy.
  • Heat shock protein 27 (HSP27) is identified as a potential therapeutic target.

Purpose of the Study:

  • To investigate the role of HSP27 in lung and head and neck cancer.
  • To evaluate the combined effect of radiotherapy and HSP27 inhibition on cancer cells.
  • To assess the impact on cell viability and migration.

Main Methods:

  • Proteomic screening of lung and head and neck cancer cell lines.
  • Treatment with irradiation and a heat shock protein 27 (HSP27) phosphorylation inhibitor (MKII).
  • Assessment of cell viability, migration, and HSP27 phosphorylation levels.
  • HSP27 knockdown experiments.

Main Results:

  • Irradiation and MKII inhibition significantly reduced viability in both cell lines.
  • MKII inhibition reduced migration in both cell lines, while irradiation only affected one.
  • HSP27 knockdown compromised viability only in A549 cells.
  • MKII inhibition counteracted radiation-induced HSP27 phosphorylation, leading to additive toxicity and reduced migration in HNSCCUM-02T cells.

Conclusions:

  • Combined inhibition of HSP27 expression/phosphorylation with radiotherapy may overcome treatment resistance.
  • Targeting HSP27 offers a potential strategy to enhance radiotherapy outcomes.
  • Further research into HSP27 as a therapeutic target in combined cancer treatment is warranted.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K